Vaccine Design for Fragile Settings: Translating Field Constraints into Product Requirements

Read full text Summarise with VIRAT
Authors: Tambe Elvis Akem
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Fragile and conflict-affected settings are home to approximately 1.9 billion people, and 26 crisis-affected countries – home to about one-quarter of the world’s infants – account for half of all unvaccinated (zero-dose) children globally. These environments generate critical vaccine design intelligence that remains systematically excluded from product development. This chapter redefines vaccine innovation for fragile and conflict-affected settings by translating frontline operational realities into concrete product design requirements. Drawing from comparative evidence across vaccine rollouts, including novel oral polio vaccine type 2 (nOPV2), measles-containing vaccine, Mpox, and Ebola vaccines in the Democratic Republic of the Congo, Liberia, South Sudan, and Nigeria, it introduces a Field-Anchored Vaccine Specification Matrix that links real-world delivery constraints to key design parameters. The chapter advances a new framework for integrating field-derived evidence into vaccine development, regulatory pathways, and procurement criteria. Positioning fragile settings as innovation laboratories, it highlights how vaccines designed for operational extremes can strengthen resilience against future outbreaks, climate-driven displacement, and emerging pathogens.

Fields of Study & Subjects

Vaccine Coverage and Hesitancy Health and Conflict Studies Immune responses and vaccinations

Publication details

Journal / source
Pharmaceutical science.
Publication date
27 March 2026
Language
EN
Document type
Book chapter